Arthritis Foundation issues CBD guidance, a first among major patient advocacy groups
The Arthritis Foundation became the first major patient advocacy group to issue CBD recommendations, telling some 50 million arthritis patients Tuesday what to look for when choosing CBD. The group did not recommend using CBD to treat arthritis symptoms, though it noted that people with arthritis show “significant use... Read more
CBD drug Epidiolex approved for use in Europe, GW Pharmaceuticals says
The only federally approved CBD product in the U.S. has been OK’d by European authorities for use there. The European Commission granted marketing authorization to Epidyolex, the trade name in Europe for Epidiolex, GW Pharmaceuticals announced Monday. In June 2018, the U.S. Food and Drug Administration approved Epidiolex for the treatment of... Read more
Canadian cannabis company planning to grow 17,000 acres of hemp in China
A Toronto marijuana producer is making plans to grow hemp in China to make CBD and other hemp products. Pure Global Cannabis announced Tuesday it signed an agreement to grow roughly 17,000 acres of hemp in the Yunnan province. Pure Global Cannabis says it will operate its China hemp... Read more
Ecuador considers hemp changes amid broader cannabis review
Ecuador may change its laws around hemp as part of a broader overhaul of how the South American country treats medical cannabis. Last week, Ecuador’s Congress approved a major reform of the Organic Integral Criminal Code. Ecuador is one of the few South American countries that still has not legalized... Read more
London cannabis investment fund acquires UK CBD manufacturer
World High Life will buy Love Hemp, which makes CBD topicals and edibles, for $11.23 million, the company announced Monday. Love Hemp products are distributed in convenience stores and drugstores. World High Life said the acquisition would give it “strong exposure to the significant and growing CBD market in... Read more
Member Blog: Cannabis Seed To Sale Transparency Provides Solution To Vaping Illnesses
by Jessica Billingsley, CEO of AkernaNCIA Board Member The day I sat beside the MRI while my daughter’s mystery neurologic symptoms were investigated, I began my crusade for product transparency. I didn’t know then that transparency in products would become life’s work. On that day, I only knew my... Read more
Members of Congress question viability of crop insurance for hemp
Congressional agriculture leaders from both parties are asking whether crop insurance for hemp will be workable. The crop insurance challenge came up Thursday in the House Agriculture Committee, where Democratic Chairman Collin Peterson of Minnesota expressed doubts that hemp could be insured in the near future, given how little is... Read more
Midwest region harvest preview: Indiana hemp farmers put focus on fiber
(Editor’s Note: This is the first of an occasional series of regional reports looking at the 2019 hemp production season leading up to harvest.) The 2019 hemp production season has been much like what many describe the hemp and CBD industry: The Wild West. In the absence of federal... Read more
Alabama to delay hemp applications, citing federal delay
Alabama has postponed for two weeks the opening of the application period for its 2020 hemp program as it awaits federal interim regulations. The registration period for growers, processors and universities will now run for four weeks, from Oct. 7 to Nov. 1, the Alabama Department of Agriculture and Industries... Read more
California hemp and cannabis testing lab raises $22.6 million
Cannalysis, a hemp and cannabis testing lab based in California, raised $22.6 million that it said will fund its expansion in the state as well as helping it to move into other marijuana markets in the U.S. The Santa Ana-based company raised the money from Canlab, a cannabis, hemp... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )